Medicinal Chemicals & Botanical Products
Canopy Growth Corp (CGC) stock: what's happening now, every material event decoded in plain English, P/E and valuation, analyst ratings, and insider buying and selling.
AllSight quality score: 48/100 — a percentile rank of Canopy Growth Corp’s fundamentals against Manufacturing peers.
Is Canopy Growth Corp overvalued? P/S looks undervalued vs its 5-year range; P/B looks undervalued vs its 5-year range.
Consensus: Hold from 27 analysts (Buy 9 · Hold 11 · Sell 7).
Average price target: $14.47 (+2229.0% vs $0.62); range $8–$28.
Wall Street analyst consensus, shown as context — not an AllSight view.
Open-market buys: 1 · Open-market sells: 75 · Net: −$2.0M
Discretionary open-market purchases are the signal; grants, option exercises and Rule 10b5-1 scheduled trades are context, not counted in the balance. Facts only — not a recommendation. Source: SEC Form 4 filings on EDGAR.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!